Cas no 10321-14-9 (3,3,3-trifluoro-2,2-dihydroxypropanoic Acid)
3,3,3-trifluoro-2,2-dihydroxypropanoic Acid Chemical and Physical Properties
Names and Identifiers
-
- 3,3,3-trifluoro-2,2-dihydroxypropanoic acid
- Trifluorbrenztraubensaeure-monohydrat
- 3,3,3-Trifluoro-2,2-dihydroxypropionsaeure
- AC1MDAVT
- Propanoic acid, 3,3,3-trifluoro-2,2-dihydroxy-
- trifluoropyruvic acid hydrate
- CTK0G7180
- 2.2-Di-hydroxy-3.3.3-trifluor-propionsaeure
- 3,3,3-trifluoro-2,2-dihydroxy-propionic acid
- TRIFLUOROPYRUVIC ACID MONOHYDRATE
- 10321-14-9
- DTXSID30385372
- KWLJNSLMDANMQG-UHFFFAOYSA-N
- 9O3
- 3,3,3-trifluoro-2,2-dihydroxypropanoic Acid
-
- Inchi: 1S/C3H3F3O4/c4-3(5,6)2(9,10)1(7)8/h9-10H,(H,7,8)
- InChI Key: KWLJNSLMDANMQG-UHFFFAOYSA-N
- SMILES: FC(C(C(=O)O)(O)O)(F)F
Computed Properties
- Exact Mass: 159.99829
- Monoisotopic Mass: 159.99834306g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 7
- Heavy Atom Count: 10
- Rotatable Bond Count: 1
- Complexity: 148
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.5
- Topological Polar Surface Area: 77.8?2
Experimental Properties
- PSA: 77.76
3,3,3-trifluoro-2,2-dihydroxypropanoic Acid Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Apollo Scientific | PC4477-5g |
Trifluoropyruvic acid monohydrate |
10321-14-9 | 5g |
£235.00 | 2025-02-21 | ||
| Apollo Scientific | PC4477-25g |
Trifluoropyruvic acid monohydrate |
10321-14-9 | 25g |
£825.00 | 2025-02-21 | ||
| Enamine | EN300-298545-1.0g |
3,3,3-trifluoro-2,2-dihydroxypropanoic acid |
10321-14-9 | 1.0g |
$0.0 | 2023-02-27 |
3,3,3-trifluoro-2,2-dihydroxypropanoic Acid Related Literature
-
1. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
-
Joseph W. Bennett,Diamond T. Jones,Blake G. Hudson,Joshua Melendez-Rivera,Robert J. Hamers,Sara E. Mason Environ. Sci.: Nano, 2020,7, 1642-1651
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
Additional information on 3,3,3-trifluoro-2,2-dihydroxypropanoic Acid
Introduction to 3,3,3-trifluoro-2,2-dihydroxypropanoic Acid (CAS No. 10321-14-9)
3,3,3-trifluoro-2,2-dihydroxypropanoic acid, identified by its CAS number 10321-14-9, is a fluorinated carboxylic acid derivative that has garnered significant attention in the field of pharmaceutical chemistry and materials science. This compound belongs to a class of molecules characterized by the presence of fluorine atoms, which are known to modulate the physicochemical properties of organic compounds, including solubility, metabolic stability, and binding affinity. The unique structural features of 3,3,3-trifluoro-2,2-dihydroxypropanoic acid make it a promising candidate for various applications, particularly in the development of novel therapeutic agents and advanced functional materials.
The molecular structure of 3,3,3-trifluoro-2,2-dihydroxypropanoic acid consists of a three-carbon chain with fluorine substituents at the third carbon position and hydroxyl groups at the second and third carbon positions. This arrangement imparts both hydrophilic and lipophilic characteristics to the molecule, allowing it to interact effectively with biological targets and environmental matrices. The presence of two hydroxyl groups enhances its reactivity, making it a versatile intermediate in synthetic chemistry.
In recent years, 3,3,3-trifluoro-2,2-dihydroxypropanoic acid has been extensively studied for its potential applications in drug discovery and development. Fluorinated compounds are widely recognized for their ability to improve pharmacokinetic profiles of drugs, including enhanced bioavailability and reduced metabolic clearance. The incorporation of fluorine atoms into drug molecules can also enhance their binding affinity to biological targets, leading to more potent and selective therapeutic agents. For instance, studies have demonstrated that fluorinated carboxylic acids exhibit improved stability against enzymatic degradation, which is crucial for the design of long-acting drugs.
One of the most compelling aspects of 3,3,3-trifluoro-2,2-dihydroxypropanoic acid is its role as a building block in the synthesis of more complex fluorinated molecules. Researchers have utilized this compound to develop novel heterocyclic scaffolds and functionalized derivatives that exhibit interesting biological activities. For example, derivatives of 3,3,3-trifluoro-2,2-dihydroxypropanoic acid have been explored as potential inhibitors of enzymes involved in inflammatory pathways. These studies highlight the compound's significance in medicinal chemistry and its potential to contribute to the development of next-generation therapeutics.
The chemical reactivity of 3,3,3-trifluoro-2,2-dihydroxypropanoic acid also makes it valuable in materials science applications. Fluorinated carboxylic acids are known for their ability to enhance material properties such as thermal stability and chemical resistance. This has led to their use in the development of advanced polymers and coatings that require high performance under harsh conditions. Additionally, the hydroxyl groups in 3,3,3-trifluoro-2,2-dihydroxypropanoic acid allow for further functionalization through esterification or etherification reactions, enabling the creation of tailored materials with specific properties.
Recent advancements in synthetic methodologies have further expanded the utility of 3,CAS No 10321-14-9。 Techniques such as fluorous chemistry have enabled efficient purification and modification of fluorinated compounds without extensive solvent exchange or chromatographic separation. This has significantly streamlined the synthesis process and made it more cost-effective for industrial applications. Moreover,the growing interest in green chemistry principles has prompted researchers to explore sustainable routes for producing CAS No 10321-14-9, including biocatalytic methods that minimize waste generation.
The biological significance of CAS No 10321-14-9 is underscored by its potential role as an intermediate in metabolic pathways relevant to human health。 While not yet widely recognized as a therapeutic agent itself,its structural features suggest that it may influence key biochemical processes。 For instance,the fluorine atom can affect enzyme kinetics by altering electron distribution around the molecule,leading to changes in substrate binding affinity。 Further research is needed to fully elucidate these mechanisms,but preliminary studies indicate promising avenues for exploration。
In conclusion,CAS No 10321-14-9 represents a fascinating compound with diverse applications spanning pharmaceuticals、materials science,and beyond。 Its unique structural features—comprising fluorine atoms、hydroxyl groups,and a carboxylic acid moiety—endow it with remarkable chemical versatility。 As research continues to uncover new synthetic strategies and biological functions,the importance of this compound is likely to grow even further。 By leveraging its potential,scientists can develop innovative solutions that address challenges across multiple scientific disciplines。
10321-14-9 (3,3,3-trifluoro-2,2-dihydroxypropanoic Acid) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)